Neuraxis, Inc. (NRXS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $5.66
• Market Cap: $23.47M
• EPS: $-1.05
• 52-Week High: $5.65
• 52-Week Low: $1.33

About Neuraxis, Inc.

Neuraxis, Inc. is a pioneering medical technology company headquartered in Versailles, Indiana, focused on the development and commercialization of advanced neuromodulation therapy devices for various neurological conditions. With a strong emphasis on innovation, the company utilizes state-of-the-art technology and research to create therapeutic solutions that significantly enhance patient outcomes and overall quality of life. Neuraxis's dedication to meeting unmet medical needs positions it ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Neuraxis, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NRXS pay dividends?

Neuraxis, Inc. (NRXS) does not currently pay a regular dividend.

What is NRXS's market cap?

Neuraxis, Inc. (NRXS) has a market capitalization of $23.47M with a current stock price of $5.66.